Breaking News Instant updates and real-time market news.

OMEX

Odyssey Marine

$7.64 /

+0.24 (+3.24%)

08:07
01/27/21
01/27
08:07
01/27/21
08:07

Odyssey Marine's First Memorial in NAFTA case published

Odyssey Marine Exploration has been notified that the First Memorial filed by Odyssey in September 2020 in its pending North American Free Trade Agreement case against Mexico has now been published by the International Centre for Settlement of Investment Disputes. The $2.3B claim against Mexico under NAFTA relates to the unlawful denial of the environmental permit for subsidiary Exploraciones Oceanicas' offshore phosphate project. The First Memorial filing is supported by documentary evidence and 20 expert reports and witness statements. In summary, this evidence includes: MERITS: Testimony from independent environmental experts that the environmental impact of ExO's phosphate project is minimal and readily mitigated by measures proposed by ExO. Witnesses with first-hand knowledge also testified that the denial of environmental approval by Mexico's prior administration was politically motivated and not justified on environmental grounds. Evidence was also submitted demonstrating that Mexico granted environmental permits to similar dredging projects in areas that are considered more environmentally sensitive than ExO's project location. RESOURCE: An independent certified marine geologist testified as to the size and character of the resource which underpins the value of the claim, commercial viability and strategic importance of the mineral concession. OPERATIONAL VIABILITY: Engineering experts testified that the project uses established dredging technology that is commonly used in Mexico and around the world. VALUE: A Phosphate market analyst testified that the project's projected CAPEX and OPEX would make the project one of the lowest cost phosphate rock resources in the world, and damages experts testified the project would be commercially viable and profitable.

TODAY'S FREE FLY STORIES

Recommendations
Natera price target raised to $150 from $127 at Piper Sandler » 05:00
02/26/21
02/26
05:00
02/26/21
05:00
NTRA

Natera

$109.33 /

-3.445 (-3.05%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTRA Natera
$109.33 /

-3.445 (-3.05%)

NTRA Natera
$109.33 /

-3.445 (-3.05%)

01/27/21 Truist
Natera initiated with a Buy at Truist
01/19/21 BTIG
Natera price target raised to $135 from $112 at BTIG
01/14/21 Piper Sandler
Natera has 'substantial opportunity' in microdeletion, says Piper Sandler
01/14/21 Canaccord
Natera price target raised to $125 from $112 at Canaccord
NTRA Natera
$109.33 /

-3.445 (-3.05%)

  • 11
    Sep
NTRA Natera
$109.33 /

-3.445 (-3.05%)

Recommendations
Twitter price target raised to $79 from $64 at Jefferies » 04:59
02/26/21
02/26
04:59
02/26/21
04:59
TWTR

Twitter

$74.55 /

+2.64 (+3.67%)

, FB

Facebook

$254.66 /

-9.68 (-3.66%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$74.55 /

+2.64 (+3.67%)

FB Facebook
$254.66 /

-9.68 (-3.66%)

TWTR Twitter
$74.55 /

+2.64 (+3.67%)

04:54 Today Pivotal Research
Twitter price target raised to $95 from $77.25 at Pivotal Research
02/25/21 KeyBanc
KeyBanc says Twitter guide reinforces view that Street understating improvement
02/25/21 BMO Capital
Twitter price target raised to $75 from $45 at BMO Capital
02/22/21 Baird
Twitter price target raised to $75 from $65 at Baird
FB Facebook
$254.66 /

-9.68 (-3.66%)

02/16/21 Loop Capital
Facebook price target raised to $370 from $330 at Loop Capital
02/10/21 Tigress Financial
Facebook has 'significant upside' at current levels, says Tigress
02/01/21 Truist
Alphabet price target raised to $2,100 from $2,000 at Truist
01/31/21 Citi
Facebook price target raised to $320 from $315 at Citi
TWTR Twitter
$74.55 /

+2.64 (+3.67%)

FB Facebook
$254.66 /

-9.68 (-3.66%)

TWTR Twitter
$74.55 /

+2.64 (+3.67%)

FB Facebook
$254.66 /

-9.68 (-3.66%)

TWTR Twitter
$74.55 /

+2.64 (+3.67%)

FB Facebook
$254.66 /

-9.68 (-3.66%)

TWTR Twitter
$74.55 /

+2.64 (+3.67%)

FB Facebook
$254.66 /

-9.68 (-3.66%)

Downgrade
Sonic Healthcare downgraded to Neutral from Buy at Goldman Sachs » 04:56
02/26/21
02/26
04:56
02/26/21
04:56
SKHHY

Sonic Healthcare

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SKHHY Sonic Healthcare
$0.00 /

+ (+0.00%)

02/18/21 Jefferies
Sonic Healthcare upgraded to Buy from Hold at Jefferies
04/01/20 JPMorgan
Sonic Healthcare downgraded to Neutral from Overweight at JPMorgan
03/20/20 Goldman Sachs
Sonic Healthcare upgraded to Buy from Neutral at Goldman Sachs
03/13/20 Jefferies
Sonic Healthcare upgraded to Buy from Hold at Jefferies
Conference/Events
UBS technology analyst to hold an analyst/industry conference call » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
CRM

Salesforce

$231.11 /

-9.45 (-3.93%)

, WDAY

Workday

$251.02 /

-11.83 (-4.50%)

, VMW

VMware

$143.67 /

-3.04 (-2.07%)

Technology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$231.11 /

-9.45 (-3.93%)

WDAY Workday
$251.02 /

-11.83 (-4.50%)

VMW VMware
$143.67 /

-3.04 (-2.07%)

CRM Salesforce
$231.11 /

-9.45 (-3.93%)

02/23/21 Cowen
Salesforce survey points to a strong quarter, says Cowen
02/17/21 Mizuho
Salesforce price target raised to $290 from $275 at Mizuho
01/25/21
Fly Intel: Top five analyst upgrades
01/25/21 Loop Capital
Salesforce upgraded to Hold from Sell at Loop Capital
WDAY Workday
$251.02 /

-11.83 (-4.50%)

02/24/21 Jefferies
Workday price target raised to $325 from $280 at Jefferies
02/23/21 Credit Suisse
Workday price target raised to $245 from $230 at Credit Suisse
02/19/21 Evercore ISI
Workday price target raised to $320 from $290 at Evercore ISI
02/19/21 Barclays
Workday price target raised to $278 from $255 at Barclays
VMW VMware
$143.67 /

-3.04 (-2.07%)

02/11/21 Cleveland Research
Cleveland Research downgrades VMware to Neutral after checks with partners
02/11/21 Cleveland Research
VMware downgraded to Neutral from Buy at Cleveland Research
02/02/21 Goldman Sachs
Dell Technologies upgraded to Buy from Neutral at Goldman Sachs
01/21/21 Goldman Sachs
VMware initiated with a Neutral at Goldman Sachs
CRM Salesforce
$231.11 /

-9.45 (-3.93%)

WDAY Workday
$251.02 /

-11.83 (-4.50%)

VMW VMware
$143.67 /

-3.04 (-2.07%)

CRM Salesforce
$231.11 /

-9.45 (-3.93%)

VMW VMware
$143.67 /

-3.04 (-2.07%)

CRM Salesforce
$231.11 /

-9.45 (-3.93%)

WDAY Workday
$251.02 /

-11.83 (-4.50%)

VMW VMware
$143.67 /

-3.04 (-2.07%)

CRM Salesforce
$231.11 /

-9.45 (-3.93%)

WDAY Workday
$251.02 /

-11.83 (-4.50%)

VMW VMware
$143.67 /

-3.04 (-2.07%)

General news
Personal Income and Outlays Consumption Expenditures to be reported at 08:30 » 04:55
02/26/21
02/26
04:55
02/26/21
04:55

January Personal Income…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Wholesale Inventories (Advance) Month over Month to be reported at 08:30 » 04:55
02/26/21
02/26
04:55
02/26/21
04:55

January Wholesale…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Week of 2/26 Baker Hughes Rig Count to be released at 13:00  04:55
02/26/21
02/26
04:55
02/26/21
04:55
 
Conference/Events
Amgen to hold a pharmaceutical update conference call from AAAAI Annual Meeting » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
AMGN

Amgen

$227.43 /

-2.68 (-1.16%)

EVP of R&D, Dr. David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$227.43 /

-2.68 (-1.16%)

AMGN Amgen
$227.43 /

-2.68 (-1.16%)

02/12/21 Morgan Stanley
Amgen court decision may have readthrough for Gilead, says Morgan Stanley
02/03/21 Credit Suisse
Amgen price target lowered to $265 from $280 at Credit Suisse
02/03/21 Cantor Fitzgerald
Amgen price target raised to $295 from $280 at Cantor Fitzgerald
02/02/21 Piper Sandler
Amgen price target lowered to $260 from $280 at Piper Sandler
AMGN Amgen
$227.43 /

-2.68 (-1.16%)

AMGN Amgen
$227.43 /

-2.68 (-1.16%)

AMGN Amgen
$227.43 /

-2.68 (-1.16%)

AMGN Amgen
$227.43 /

-2.68 (-1.16%)

Conference/Events
Credit Suisse to hold a virtual forum » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
AFG

American Financial Group

$108.72 /

-3.84 (-3.41%)

, ALAB

Alabama National Bancorp

$0.00 /

+ (+0.00%)

, APO

Apollo Global

$48.88 /

-2.14 (-4.19%)

, BRO

Brown & Brown

$46.73 /

-1.065 (-2.23%)

, BPOP

Popular

$67.57 /

-1.585 (-2.29%)

, EVER

EverQuote

$49.69 /

-2.15 (-4.15%)

, SCU

Sculptor Capital

$20.70 /

-0.62 (-2.91%)

, STT

State Street

$74.26 /

-2.55 (-3.32%)

, SLM

Sallie Mae

$14.99 /

-0.23 (-1.51%)

, FOCS

Focus Financial

$52.50 /

-0.65 (-1.22%)

, GS

Goldman Sachs

$327.65 /

-3.04 (-0.92%)

, HIG

Hartford Financial

$51.87 /

-1.29 (-2.43%)

, JPM

JPMorgan

$151.18 /

-2.16 (-1.41%)

, ELVT

Elevate Credit

$4.13 /

-0.12 (-2.82%)

, COOP

Mr. Cooper

$30.06 /

-1.29 (-4.11%)

, CME

CME Group

$204.62 /

+3.72 (+1.85%)

, FCFS

FirstCash

$65.28 /

-0.74 (-1.12%)

, CBOE

Cboe Global Markets

$100.13 /

+0.3 (+0.30%)

, SIGI

Selective Insurance

$68.19 /

-1.3 (-1.87%)

, WFC

Wells Fargo

$37.56 /

-0.74 (-1.93%)

, WETF

WisdomTree

$5.52 /

-0.23 (-4.00%)

, TWO

Two Harbors

$7.07 /

-0.27 (-3.68%)

, TW

Tradeweb Markets

$73.77 /

+3.2 (+4.53%)

, BLK

BlackRock

$694.55 /

-17.965 (-2.52%)

, BK

BNY Mellon

$43.41 /

-0.83 (-1.88%)

, BAC

Bank of America

$35.93 /

-0.44 (-1.21%)

22nd Annual Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AFG American Financial Group
$108.72 /

-3.84 (-3.41%)

APO Apollo Global
$48.88 /

-2.14 (-4.19%)

BRO Brown & Brown
$46.73 /

-1.065 (-2.23%)

BPOP Popular
$67.57 /

-1.585 (-2.29%)

EVER EverQuote
$49.69 /

-2.15 (-4.15%)

SCU Sculptor Capital
$20.70 /

-0.62 (-2.91%)

STT State Street
$74.26 /

-2.55 (-3.32%)

SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

GS Goldman Sachs
$327.65 /

-3.04 (-0.92%)

HIG Hartford Financial
$51.87 /

-1.29 (-2.43%)

JPM JPMorgan
$151.18 /

-2.16 (-1.41%)

ELVT Elevate Credit
$4.13 /

-0.12 (-2.82%)

COOP Mr. Cooper
$30.06 /

-1.29 (-4.11%)

CME CME Group
$204.62 /

+3.72 (+1.85%)

FCFS FirstCash
$65.28 /

-0.74 (-1.12%)

CBOE Cboe Global Markets
$100.13 /

+0.3 (+0.30%)

SIGI Selective Insurance
$68.19 /

-1.3 (-1.87%)

WFC Wells Fargo
$37.56 /

-0.74 (-1.93%)

WETF WisdomTree
$5.52 /

-0.23 (-4.00%)

TW Tradeweb Markets
$73.77 /

+3.2 (+4.53%)

BLK BlackRock
$694.55 /

-17.965 (-2.52%)

BK BNY Mellon
$43.41 /

-0.83 (-1.88%)

BAC Bank of America
$35.93 /

-0.44 (-1.21%)

AFG American Financial Group
$108.72 /

-3.84 (-3.41%)

02/22/21 Piper Sandler
American Financial Group price target raised to $125 from $110 at Piper Sandler
01/28/21 Credit Suisse
American Financial Group price target raised to $110 from $95.75 at Credit Suisse
09/30/20 Credit Suisse
American Financial Group initiated with an Outperform at Credit Suisse
08/13/20 Raymond James
American Financial Group upgraded at Raymond James on better outlook visibility
ALAB Alabama National Bancorp
$0.00 /

+ (+0.00%)

APO Apollo Global
$48.88 /

-2.14 (-4.19%)

01/20/21 Truist
Athene Holding price target raised to $55 from $48 at Truist
01/11/21 Wells Fargo
Apollo Global price target raised to $55 from $50 at Wells Fargo
12/18/20 Deutsche Bank
Apollo Global price target raised to $51 from $49 at Deutsche Bank
11/06/20
Fly Intel: Top five analyst upgrades
BRO Brown & Brown
$46.73 /

-1.065 (-2.23%)

01/18/21 Keefe Bruyette
Brown & Brown upgraded to Outperform from Market Perform at Keefe Bruyette
01/15/21 Deutsche Bank
Brown & Brown named 'Catalyst Call: Buy Idea' at Deutsche Bank
01/08/21 Goldman Sachs
Brown & Brown upgraded to Buy from Neutral at Goldman Sachs
12/31/20 Credit Suisse
Brown & Brown price target raised to $50 from $47 at Credit Suisse
BPOP Popular
$67.57 /

-1.585 (-2.29%)

01/29/21 RBC Capital
Popular price target raised to $70 from $48 at RBC Capital
01/08/21 UBS
Popular upgraded to Buy from Neutral at UBS
09/22/20
Top five analyst initiations
09/22/20 UBS
Popular initiated with a Neutral at UBS
EVER EverQuote
$49.69 /

-2.15 (-4.15%)

02/23/21 Oppenheimer
EverQuote price target raised to $70 from $55 at Oppenheimer
12/16/20 JPMorgan
EverQuote price target lowered to $48 from $54 at JPMorgan
11/03/20 Raymond James
EverQuote price target lowered to $51 from $63 at Raymond James
11/03/20 JPMorgan
EverQuote price target lowered to $54 from $60 at JPMorgan
SCU Sculptor Capital
$20.70 /

-0.62 (-2.91%)

12/18/20 Citi
Citi opens '90-Day Catalyst Watch' on Sculptor Capital
12/16/20 Citi
Sculptor Capital price target raised to $26.50 from $25 at Citi
09/29/20 Citi
Citi opens '90-Day Positive Catalyst Watch' on Sculptor Capital
07/24/20 Citi
Citi boosts Sculptor Capital target, opens 'Positive Catalyst Watch'
STT State Street
$74.26 /

-2.55 (-3.32%)

01/21/21 Wells Fargo
State Street price target raised to $83 from $75 at Wells Fargo
01/20/21 RBC Capital
State Street price target raised to $86 from $78 at RBC Capital
01/11/21 Piper Sandler
State Street price target raised to $81 from $69 at Piper Sandler
01/05/21 Wolfe Research
State Street downgraded to Underperform from Peer Perform at Wolfe Research
SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

01/29/21 Barclays
Sallie Mae price target raised to $18 from $15 at Barclays
01/29/21 RBC Capital
Sallie Mae upgraded to Outperform from Sector Perform at RBC Capital
01/29/21 Citi
Sallie Mae price target raised to $16 from $12 at Citi
01/29/21 RBC Capital
Sallie Mae upgraded to Outperform from Sector Perform at RBC Capital
FOCS Focus Financial
$52.50 /

-0.65 (-1.22%)

02/19/21 Keefe Bruyette
Focus Financial price target raised to $61 from $54 at Keefe Bruyette
08/04/20 Truist
Focus Financial price target raised to $50 from $30 at Truist
06/30/20 Goldman Sachs
Focus Financial upgraded to Buy from Neutral at Goldman Sachs
06/22/20 Credit Suisse
Focus Financial Partners initiated with an Outperform at Credit Suisse
GS Goldman Sachs
$327.65 /

-3.04 (-0.92%)

02/24/21 Wells Fargo
Goldman Sachs price target raised to $360 from $335 at Wells Fargo
01/28/21 Deutsche Bank
Goldman Sachs price target raised to $310 from $290 at Deutsche Bank
01/22/21 Citi
Goldman Sachs price target raised to $370 from $357 at Citi
01/20/21 Credit Suisse
Goldman Sachs price target raised to $345 from $325 at Credit Suisse
HIG Hartford Financial
$51.87 /

-1.29 (-2.43%)

02/19/21 Raymond James
Hartford Financial initiated with an Outperform at Raymond James
02/18/21 Raymond James
Hartford Financial initiated with an Outperform at Raymond James
02/08/21 RBC Capital
Hartford Financial price target raised to $51 from $43 at RBC Capital
01/04/21 JPMorgan
Hartford Financial upgraded to Overweight with $55 target at JPMorgan
JPM JPMorgan
$151.18 /

-2.16 (-1.41%)

01/19/21 DA Davidson
JPMorgan price target raised to $163 from $147 at DA Davidson
01/19/21 Seaport Global
JPMorgan price target raised to $157 from $140 at Seaport Global
01/19/21 RBC Capital
JPMorgan price target raised to $150 from $130 at RBC Capital
01/19/21 Credit Suisse
JPMorgan price target raised to $150 from $142 at Credit Suisse
ELVT Elevate Credit
$4.13 /

-0.12 (-2.82%)

04/14/20 Maxim
LendingClub, Enova International, Elevate Credit cut to Hold at Maxim
04/14/20 Maxim
Elevate Credit downgraded to Hold from Buy at Maxim
COOP Mr. Cooper
$30.06 /

-1.29 (-4.11%)

02/24/21 Credit Suisse
Mr. Cooper price target raised to $40 from $34 at Credit Suisse
12/14/20 Jefferies
Mr. Cooper initiated with a Hold at Jefferies
12/10/20 Barclays
Mr. Cooper price target raised to $38 from $28 at Barclays
11/30/20 Wedbush
Mr. Cooper price target raised to $34 from $27.50 at Wedbush
CME CME Group
$204.62 /

+3.72 (+1.85%)

02/25/21 Wells Fargo
CME Group upgraded to Overweight at Wells Fargo
02/25/21 Wells Fargo
CME Group upgraded to Overweight from Equal Weight at Wells Fargo
02/11/21 Citi
CME Group price target lowered to $207 from $210 at Citi
01/15/21 Oppenheimer
CME Group downgraded to Perform on valuation at Oppenheimer
FCFS FirstCash
$65.28 /

-0.74 (-1.12%)

09/03/20 Credit Suisse
Credit Suisse upgrades FirstCash ahead of expected earnings recovery
09/03/20 Credit Suisse
FirstCash upgraded to Outperform from Neutral at Credit Suisse
08/12/20 Barclays
FirstCash upgraded to Overweight ahead of expected 2H recovery at Barclays
08/12/20 Barclays
FirstCash upgraded to Overweight from Equal Weight at Barclays
CBOE Cboe Global Markets
$100.13 /

+0.3 (+0.30%)

02/08/21 Deutsche Bank
Cboe Global Markets price target lowered to $103 from $108 at Deutsche Bank
01/07/21 Wells Fargo
Cboe Global Markets price target raised to $110 from $105 at Wells Fargo
01/07/21 JPMorgan
Cboe downgraded to Underweight with $93 target at JPMorgan
01/07/21 JPMorgan
Cboe Global Markets downgraded to Underweight from Neutral at JPMorgan
SIGI Selective Insurance
$68.19 /

-1.3 (-1.87%)

11/10/20 Credit Suisse
Selective Insurance price target raised to $71 from $66 at Credit Suisse
05/14/20 Credit Suisse
Selective Insurance upgraded to Outperform from Underperform at Credit Suisse
03/09/20 JMP Securities
Selective Insurance upgraded to Outperform at JMP Securities
WFC Wells Fargo
$37.56 /

-0.74 (-1.93%)

02/18/21
Fly Intel: Top five analyst upgrades
02/18/21 JPMorgan
Wells Fargo upgraded to Neutral with cap lift closer at JPMorgan
02/18/21 JPMorgan
Wells Fargo upgraded to Neutral from Underweight at JPMorgan
02/17/21 Goldman Sachs
Goldman says Fed approving Wells' risk overhaul plan would be 'important step'
WETF WisdomTree
$5.52 /

-0.23 (-4.00%)

02/01/21 Deutsche Bank
WisdomTree price target raised to $6 from $5 at Deutsche Bank
01/11/21 Morgan Stanley
WisdomTree downgraded to Underweight after 50% rally at Morgan Stanley
01/11/21 Morgan Stanley
WisdomTree downgraded to Underweight from Equal Weight at Morgan Stanley
12/29/20 Northland
WisdomTree price target raised to $6 from $4.25 at Northland
TWO Two Harbors
$7.07 /

-0.27 (-3.68%)

12/18/20 Keefe Bruyette
Two Harbors downgraded to Market Perform from Outperform at Keefe Bruyette
12/14/20 Jefferies
Two Harbors initiated with a Hold at Jefferies
12/10/20 Barclays
Two Harbors downgraded to Equal Weight from Overweight at Barclays
11/24/20 Raymond James
Two Harbors downgraded to Market Perform from Outperform at Raymond James
TW Tradeweb Markets
$73.77 /

+3.2 (+4.53%)

02/22/21 Goldman Sachs
Tradeweb Markets upgraded to Buy from Neutral at Goldman Sachs
01/13/21 Compass Point
Tradeweb Markets upgraded in relative call against MarketAxess at Compass Point
01/13/21 Compass Point
Tradeweb Markets upgraded to Buy from Neutral at Compass Point
09/14/20 Rosenblatt
Tradeweb Markets upgraded to Buy from Neutral at Rosenblatt
BLK BlackRock
$694.55 /

-17.965 (-2.52%)

02/22/21 Stifel
GasLog downgraded to Hold from Buy at Stifel
01/19/21 RBC Capital
PNC Financial price target raised to $161 from $135 at RBC Capital
01/15/21 BMO Capital
BlackRock price target raised to $715 from $709 at BMO Capital
01/15/21 Deutsche Bank
BlackRock price target raised to $838 from $835 at Deutsche Bank
BK BNY Mellon
$43.41 /

-0.83 (-1.88%)

01/21/21 RBC Capital
BNY Mellon price target raised to $49 from $43 at RBC Capital
01/21/21 Citi
BNY Mellon earnings selloff a 'bit overdone,' says Citi
01/11/21 Citi
BNY Mellon upgraded to Buy from Neutral at Citi
01/11/21 Citi
BNY Mellon upgraded to Buy from Neutral at Citi
BAC Bank of America
$35.93 /

-0.44 (-1.21%)

02/22/21 Wells Fargo
Wells Fargo boosts Bank of America target, sees path to $55 per share
01/26/21 Atlantic Equities
Bank of America upgraded to Overweight from Neutral at Atlantic Equities
01/20/21 RBC Capital
Bank of America price target raised to $37 from $28 at RBC Capital
01/11/21 Citi
Bank of America upgraded to Buy from Neutral at Citi
AFG American Financial Group
$108.72 /

-3.84 (-3.41%)

APO Apollo Global
$48.88 /

-2.14 (-4.19%)

BRO Brown & Brown
$46.73 /

-1.065 (-2.23%)

BPOP Popular
$67.57 /

-1.585 (-2.29%)

EVER EverQuote
$49.69 /

-2.15 (-4.15%)

STT State Street
$74.26 /

-2.55 (-3.32%)

SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

FOCS Focus Financial
$52.50 /

-0.65 (-1.22%)

GS Goldman Sachs
$327.65 /

-3.04 (-0.92%)

HIG Hartford Financial
$51.87 /

-1.29 (-2.43%)

JPM JPMorgan
$151.18 /

-2.16 (-1.41%)

ELVT Elevate Credit
$4.13 /

-0.12 (-2.82%)

COOP Mr. Cooper
$30.06 /

-1.29 (-4.11%)

CME CME Group
$204.62 /

+3.72 (+1.85%)

FCFS FirstCash
$65.28 /

-0.74 (-1.12%)

CBOE Cboe Global Markets
$100.13 /

+0.3 (+0.30%)

SIGI Selective Insurance
$68.19 /

-1.3 (-1.87%)

WFC Wells Fargo
$37.56 /

-0.74 (-1.93%)

WETF WisdomTree
$5.52 /

-0.23 (-4.00%)

TWO Two Harbors
$7.07 /

-0.27 (-3.68%)

TW Tradeweb Markets
$73.77 /

+3.2 (+4.53%)

BLK BlackRock
$694.55 /

-17.965 (-2.52%)

BK BNY Mellon
$43.41 /

-0.83 (-1.88%)

BAC Bank of America
$35.93 /

-0.44 (-1.21%)

  • 26
    Feb
  • 13
    May
  • 23
    Apr
APO Apollo Global
$48.88 /

-2.14 (-4.19%)

STT State Street
$74.26 /

-2.55 (-3.32%)

GS Goldman Sachs
$327.65 /

-3.04 (-0.92%)

JPM JPMorgan
$151.18 /

-2.16 (-1.41%)

CME CME Group
$204.62 /

+3.72 (+1.85%)

CBOE Cboe Global Markets
$100.13 /

+0.3 (+0.30%)

WFC Wells Fargo
$37.56 /

-0.74 (-1.93%)

BLK BlackRock
$694.55 /

-17.965 (-2.52%)

BK BNY Mellon
$43.41 /

-0.83 (-1.88%)

BAC Bank of America
$35.93 /

-0.44 (-1.21%)

AFG American Financial Group
$108.72 /

-3.84 (-3.41%)

APO Apollo Global
$48.88 /

-2.14 (-4.19%)

EVER EverQuote
$49.69 /

-2.15 (-4.15%)

STT State Street
$74.26 /

-2.55 (-3.32%)

SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

GS Goldman Sachs
$327.65 /

-3.04 (-0.92%)

JPM JPMorgan
$151.18 /

-2.16 (-1.41%)

ELVT Elevate Credit
$4.13 /

-0.12 (-2.82%)

CME CME Group
$204.62 /

+3.72 (+1.85%)

CBOE Cboe Global Markets
$100.13 /

+0.3 (+0.30%)

WFC Wells Fargo
$37.56 /

-0.74 (-1.93%)

BLK BlackRock
$694.55 /

-17.965 (-2.52%)

BK BNY Mellon
$43.41 /

-0.83 (-1.88%)

BAC Bank of America
$35.93 /

-0.44 (-1.21%)

APO Apollo Global
$48.88 /

-2.14 (-4.19%)

SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

GS Goldman Sachs
$327.65 /

-3.04 (-0.92%)

CME CME Group
$204.62 /

+3.72 (+1.85%)

CBOE Cboe Global Markets
$100.13 /

+0.3 (+0.30%)

WFC Wells Fargo
$37.56 /

-0.74 (-1.93%)

BLK BlackRock
$694.55 /

-17.965 (-2.52%)

BAC Bank of America
$35.93 /

-0.44 (-1.21%)

Conference/Events
SVB Leerink to hold a virtual conference » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
ACRS

Aclaris Therapeutics

$21.24 /

+0.52 (+2.51%)

, BBIO

BridgeBio

$65.26 /

-2.3001 (-3.40%)

, HLIO

Helios Technologies

$65.84 /

-1.11 (-1.66%)

, MTCR

Metracrine

$8.57 /

-0.24 (-2.72%)

, SIEN

Sientra

$7.70 /

-0.355 (-4.41%)

, TRVI

Trevi Therapeutics

$2.82 /

-0.07 (-2.42%)

, VCYT

Veracyte

$58.71 /

-3.635 (-5.83%)

, VINC

Vincera Pharma

$19.19 /

-0.92 (-4.57%)

, CTSO

CytoSorbents

$9.70 /

-0.44 (-4.34%)

, CTLT

Catalent

$112.25 /

-2.87 (-2.49%)

, IMRA

Imara

$12.49 /

-0.45 (-3.48%)

, ITOS

iTeos Therapeutics

$41.77 /

+0.77 (+1.88%)

, LLY

Eli Lilly

$203.91 /

-0.735 (-0.36%)

, AUPH

Aurinia Pharmaceuticals

$14.59 /

+0.015 (+0.10%)

, AVXL

Anavex

$13.01 /

+0.65 (+5.26%)

, DRIO

DarioHealth

$27.17 /

-2.22 (-7.55%)

, ENTA

Enanta

$50.58 /

-1.1548 (-2.23%)

, EQ

Equillium

$7.65 /

-0.22 (-2.80%)

, EXEL

Exelixis

$21.96 /

-0.73 (-3.22%)

, SDGR

Schrodinger

$104.43 /

-6.46 (-5.83%)

10th Annual Global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$21.24 /

+0.52 (+2.51%)

BBIO BridgeBio
$65.26 /

-2.3001 (-3.40%)

HLIO Helios Technologies
$65.84 /

-1.11 (-1.66%)

MTCR Metracrine
$8.57 /

-0.24 (-2.72%)

SIEN Sientra
$7.70 /

-0.355 (-4.41%)

TRVI Trevi Therapeutics
$2.82 /

-0.07 (-2.42%)

VCYT Veracyte
$58.71 /

-3.635 (-5.83%)

VINC Vincera Pharma
$19.19 /

-0.92 (-4.57%)

CTSO CytoSorbents
$9.70 /

-0.44 (-4.34%)

CTLT Catalent
$112.25 /

-2.87 (-2.49%)

IMRA Imara
$12.49 /

-0.45 (-3.48%)

ITOS iTeos Therapeutics
$41.77 /

+0.77 (+1.88%)

LLY Eli Lilly
$203.91 /

-0.735 (-0.36%)

AUPH Aurinia Pharmaceuticals
$14.59 /

+0.015 (+0.10%)

AVXL Anavex
$13.01 /

+0.65 (+5.26%)

DRIO DarioHealth
$27.17 /

-2.22 (-7.55%)

ENTA Enanta
$50.58 /

-1.1548 (-2.23%)

EQ Equillium
$7.65 /

-0.22 (-2.80%)

EXEL Exelixis
$21.96 /

-0.73 (-3.22%)

SDGR Schrodinger
$104.43 /

-6.46 (-5.83%)

ACRS Aclaris Therapeutics
$21.24 /

+0.52 (+2.51%)

02/02/21 Cantor Fitzgerald
Aclaris Therapeutics price target raised to $30 from $15 at Cantor Fitzgerald
01/19/21 William Blair
Aclaris has potential in range of 'blockbuster indications,' says William Blair
BBIO BridgeBio
$65.26 /

-2.3001 (-3.40%)

02/22/21 JPMorgan
BridgeBio reinstated with an Overweight at JPMorgan
02/09/21
Fly Intel: Top five analyst initiations
02/09/21 Goldman Sachs
BridgeBio reinstated with a Buy at Goldman Sachs
01/11/21 H.C. Wainwright
BridgeBio price target raised to $87 from $64 at H.C. Wainwright
HLIO Helios Technologies
$65.84 /

-1.11 (-1.66%)

10/12/20 Baird
Helios Technologies upgraded to Outperform from Neutral at Baird
05/29/20 Morgan Stanley
Morgan Stanley upgrades Helios to Equal Weight following underperformance
05/29/20 Morgan Stanley
Helios Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
03/27/20 SunTrust
Helios Technologies price target lowered to $36 from $45 at SunTrust
MTCR Metracrine
$8.57 /

-0.24 (-2.72%)

10/12/20 Canaccord
Metracrine initiated with a Buy at Canaccord
10/12/20 Jefferies
Metracrine initiated with a Buy at Jefferies
10/12/20 RBC Capital
Metracrine initiated with an Outperform at RBC Capital
SIEN Sientra
$7.70 /

-0.355 (-4.41%)

02/05/21 Canaccord
Sientra price target raised to $8 from $6 at Canaccord
10/08/20 Stifel
Stifel sees upside potential for Sientra after survey of aesthetics doctors
06/11/20 Maxim
Sientra price target raised to $8 from $5 at Maxim
03/12/20 Craig-Hallum
Sientra price target lowered to $9 from $14 at Craig-Hallum
TRVI Trevi Therapeutics
$2.82 /

-0.07 (-2.42%)

07/13/20 Stifel
Trevi Therapeutics price target lowered to $10 from $14 at Stifel
VCYT Veracyte
$58.71 /

-3.635 (-5.83%)

02/18/21 Needham
Veracyte assumed with a Buy at Needham
02/08/21 SVB Leerink
Veracyte price target raised to $83 from $40 at SVB Leerink
01/27/21 Truist
Veracyte initiated with a Buy at Truist
12/17/20 Lake Street
Veracyte price target raised to $60 from $40 at Lake Street
VINC Vincera Pharma
$19.19 /

-0.92 (-4.57%)

01/06/21 Chardan
Vincera Pharma initiated with a Buy at Chardan
CTSO CytoSorbents
$9.70 /

-0.44 (-4.34%)

01/04/21 B. Riley Securities
CytoSorbents price target raised to $17 from $16 at B. Riley Securities
09/01/20 SVB Leerink
CytoSorbents initiated with an Outperform at SVB Leerink
08/25/20 B. Riley FBR
CytoSorbents 29% pullback from highs a buying opportunity, says B. Riley FBR
06/02/20 B. Riley FBR
CytoSorbents gaining relevance as COVID-19 treatment, says B. Riley FBR
CTLT Catalent
$112.25 /

-2.87 (-2.49%)

02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
01/08/21 JPMorgan
Catalent price target raised to $130 from $110 at JPMorgan
01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
IMRA Imara
$12.49 /

-0.45 (-3.48%)

01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
06/30/20 Citi
Imara downgraded to Neutral from Buy at Citi
ITOS iTeos Therapeutics
$41.77 /

+0.77 (+1.88%)

10/07/20 Baird
iTeos Therapeutics initiated with an Outperform at Baird
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/01/20 Piper Sandler
iTeos Therapeutics heading for 'catalyst rich stretch', says Piper Sandler
08/18/20 SVB Leerink
SVB Leerink bullish on iTeos Therapeutics, initiates with an Outperform
LLY Eli Lilly
$203.91 /

-0.735 (-0.36%)

02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
02/18/21 Piper Sandler
Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler
02/12/21 Cowen
Eli Lilly price target raised to $235 from $195 at Cowen
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
AUPH Aurinia Pharmaceuticals
$14.59 /

+0.015 (+0.10%)

01/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $28 from $20 at RBC Capital
01/26/21 Cantor Fitzgerald
Aurinia Pharmaceuticals price target raised to $34 from $27 at Cantor Fitzgerald
01/25/21 Oppenheimer
Aurinia Pharmaceuticals price target raised to $28 from $20 at Oppenheimer
01/25/21 H.C. Wainwright
Aurinia Pharmaceuticals price target raised to $35 from $30 at H.C. Wainwright
AVXL Anavex
$13.01 /

+0.65 (+5.26%)

02/24/21 Cantor Fitzgerald
Anavex price target raised to $25 from $10 at Cantor Fitzgerald
02/23/21 Cantor Fitzgerald
Anavex price target raised to $25 from $10 at Cantor Fitzgerald
12/29/20 Cantor Fitzgerald
Anavex cash position to fund operations into 2022, says Cantor Fitzgerald
12/16/20 H.C. Wainwright
Anavex price target raised to $17 from $14 at H.C. Wainwright
DRIO DarioHealth
$27.17 /

-2.22 (-7.55%)

02/01/21 Alliance Global Partners
DarioHealth downgraded to Neutral from Buy at Alliance Global Partners
08/17/20 Aegis
DarioHealth initiated with a Buy at Aegis
08/13/20 Craig-Hallum
DarioHealth price target raised to $17 from $8 at Craig-Hallum
06/22/20 ThinkEquity
DarioHealth initiated with a Buy at ThinkEquity
ENTA Enanta
$50.58 /

-1.1548 (-2.23%)

02/09/21 RBC Capital
Enanta price target raised to $53 from $47 at RBC Capital
01/29/21 JPMorgan
Enanta upgraded to Neutral with $55 target at JPMorgan
01/29/21 JPMorgan
Enanta upgraded to Neutral from Underweight at JPMorgan
01/08/21 Piper Sandler
Enanta remains 'significantly undervalued,' says Piper Sandler
EQ Equillium
$7.65 /

-0.22 (-2.80%)

11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
07/10/20 Stifel
Equillium transferred with Buy rating, $10 target at Stifel
EXEL Exelixis
$21.96 /

-0.73 (-3.22%)

02/15/21 Piper Sandler
Exelixis price target raised to $36 from $33 at Piper Sandler
01/25/21 Piper Sandler
Piper says Exelixis could have 'blockbuster opportunity' with XL102
01/22/21 Piper Sandler
Exelixis combo approval came a month ahead of PDUFA, says Piper Sandler
01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
SDGR Schrodinger
$104.43 /

-6.46 (-5.83%)

01/25/21 BMO Capital
Schrodinger price target raised to $117 from $97 at BMO Capital
11/23/20 BofA
BofA upgrades Schrodinger to Buy after 'major' collaboration announcement
11/23/20 BofA
Schrodinger upgraded to Buy from Neutral at BofA
10/12/20 Jefferies
Schrodinger upgraded to Buy from Hold at Jefferies
ACRS Aclaris Therapeutics
$21.24 /

+0.52 (+2.51%)

BBIO BridgeBio
$65.26 /

-2.3001 (-3.40%)

HLIO Helios Technologies
$65.84 /

-1.11 (-1.66%)

MTCR Metracrine
$8.57 /

-0.24 (-2.72%)

SIEN Sientra
$7.70 /

-0.355 (-4.41%)

VCYT Veracyte
$58.71 /

-3.635 (-5.83%)

CTSO CytoSorbents
$9.70 /

-0.44 (-4.34%)

CTLT Catalent
$112.25 /

-2.87 (-2.49%)

IMRA Imara
$12.49 /

-0.45 (-3.48%)

ITOS iTeos Therapeutics
$41.77 /

+0.77 (+1.88%)

LLY Eli Lilly
$203.91 /

-0.735 (-0.36%)

AUPH Aurinia Pharmaceuticals
$14.59 /

+0.015 (+0.10%)

AVXL Anavex
$13.01 /

+0.65 (+5.26%)

DRIO DarioHealth
$27.17 /

-2.22 (-7.55%)

ENTA Enanta
$50.58 /

-1.1548 (-2.23%)

EQ Equillium
$7.65 /

-0.22 (-2.80%)

EXEL Exelixis
$21.96 /

-0.73 (-3.22%)

SDGR Schrodinger
$104.43 /

-6.46 (-5.83%)

  • 12
    Feb
  • 09
    Feb
  • 05
    Feb
  • 20
    Jan
  • 23
    Nov
  • 16
    Sep
  • 14
    Aug
  • 13
    Aug
  • 05
    Aug
  • 24
    Jul
  • 23
    Jul
  • 22
    Jul
  • 11
    Jun
  • 29
    May
  • 12
    Mar
BBIO BridgeBio
$65.26 /

-2.3001 (-3.40%)

LLY Eli Lilly
$203.91 /

-0.735 (-0.36%)

AUPH Aurinia Pharmaceuticals
$14.59 /

+0.015 (+0.10%)

ACRS Aclaris Therapeutics
$21.24 /

+0.52 (+2.51%)

BBIO BridgeBio
$65.26 /

-2.3001 (-3.40%)

MTCR Metracrine
$8.57 /

-0.24 (-2.72%)

SIEN Sientra
$7.70 /

-0.355 (-4.41%)

VCYT Veracyte
$58.71 /

-3.635 (-5.83%)

VINC Vincera Pharma
$19.19 /

-0.92 (-4.57%)

CTLT Catalent
$112.25 /

-2.87 (-2.49%)

IMRA Imara
$12.49 /

-0.45 (-3.48%)

LLY Eli Lilly
$203.91 /

-0.735 (-0.36%)

AUPH Aurinia Pharmaceuticals
$14.59 /

+0.015 (+0.10%)

AVXL Anavex
$13.01 /

+0.65 (+5.26%)

ENTA Enanta
$50.58 /

-1.1548 (-2.23%)

EQ Equillium
$7.65 /

-0.22 (-2.80%)

EXEL Exelixis
$21.96 /

-0.73 (-3.22%)

SDGR Schrodinger
$104.43 /

-6.46 (-5.83%)

LLY Eli Lilly
$203.91 /

-0.735 (-0.36%)

AUPH Aurinia Pharmaceuticals
$14.59 /

+0.015 (+0.10%)

SDGR Schrodinger
$104.43 /

-6.46 (-5.83%)

Conference/Events
SailPoint to host analyst day » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
SAIL

SailPoint

$56.59 /

-3.03 (-5.08%)

Analyst Day to be held on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAIL SailPoint
$56.59 /

-3.03 (-5.08%)

SAIL SailPoint
$56.59 /

-3.03 (-5.08%)

02/16/21 Canaccord
SailPoint price target raised to $70 from $53 at Canaccord
01/27/21 RBC Capital
SailPoint price target raised to $68 from $55 at RBC Capital
01/27/21 Truist
SailPoint price target raised to $65 from $55 at Truist
01/08/21 Morgan Stanley
SailPoint price target raised to $71 from $63 at Morgan Stanley
SAIL SailPoint
$56.59 /

-3.03 (-5.08%)

SAIL SailPoint
$56.59 /

-3.03 (-5.08%)

Conference/Events
RBC Capital Markets to hold a virtual conference » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
F

Ford

$11.77 /

-0.5 (-4.08%)

, AZEK

Azek

$43.51 /

-2.29 (-5.00%)

, EQIX

Equinix

$638.01 /

+0.02 (+0.00%)

, SHOP

Shopify

$1,244.50 /

-56.01 (-4.31%)

Global ESG Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
F Ford
$11.77 /

-0.5 (-4.08%)

AZEK Azek
$43.51 /

-2.29 (-5.00%)

EQIX Equinix
$638.01 /

+0.02 (+0.00%)

SHOP Shopify
$1,244.50 /

-56.01 (-4.31%)

F Ford
$11.77 /

-0.5 (-4.08%)

02/24/21 Roth Capital
Roth cuts Workhorse target to $15 after 'highly unusual' contract loss
02/16/21 Wedbush
Wedbush expects Apple to announce formal EV partnership in 2021
02/09/21
Fly Intel: Top five analyst upgrades
02/09/21 Argus
Ford upgraded to Buy from Hold at Argus
AZEK Azek
$43.51 /

-2.29 (-5.00%)

02/12/21 B. Riley Securities
Azek price target raised to $50 from $48 at B. Riley Securities
02/12/21 Barclays
Azek price target raised to $51 from $44 at Barclays
02/12/21 Citi
Azek price target raised to $47 from $42 at Citi
01/26/21 RBC Capital
Azek price target raised to $50 from $43 at RBC Capital
EQIX Equinix
$638.01 /

+0.02 (+0.00%)

02/12/21 Citi
Equinix price target lowered to $849 from $883 at Citi
02/11/21 Credit Suisse
Equinix price target raised to $942 from $915 at Credit Suisse
02/11/21 Raymond James
Equinix price target raised to $856 from $835 at Raymond James
02/11/21 Cowen
Equinix price target lowered to $811 from $864 at Cowen
SHOP Shopify
$1,244.50 /

-56.01 (-4.31%)

02/19/21 Mizuho
Shopify price target raised to $1,300 from $1,050 at Mizuho
02/18/21 RBC Capital
Shopify price target raised to $1,500 from $1,290 at RBC Capital
02/18/21 Truist
Shopify price target raised to $1,475 from $1,100 at Truist
02/18/21 DA Davidson
Shopify price target raised to $1,275 from $1,000 at DA Davidson
F Ford
$11.77 /

-0.5 (-4.08%)

AZEK Azek
$43.51 /

-2.29 (-5.00%)

EQIX Equinix
$638.01 /

+0.02 (+0.00%)

SHOP Shopify
$1,244.50 /

-56.01 (-4.31%)

  • 23
    Feb
  • 22
    Jan
  • 16
    Sep
  • 11
    Sep
  • 12
    Jun
  • 12
    May
  • 08
    May
F Ford
$11.77 /

-0.5 (-4.08%)

AZEK Azek
$43.51 /

-2.29 (-5.00%)

EQIX Equinix
$638.01 /

+0.02 (+0.00%)

SHOP Shopify
$1,244.50 /

-56.01 (-4.31%)

F Ford
$11.77 /

-0.5 (-4.08%)

AZEK Azek
$43.51 /

-2.29 (-5.00%)

SHOP Shopify
$1,244.50 /

-56.01 (-4.31%)

F Ford
$11.77 /

-0.5 (-4.08%)

SHOP Shopify
$1,244.50 /

-56.01 (-4.31%)

Conference/Events
Akouos participates in a conference call hosted by Truist » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
AKUS

Akouos

$19.86 /

+1.31 (+7.06%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
AKUS Akouos
$19.86 /

+1.31 (+7.06%)

AKUS Akouos
$19.86 /

+1.31 (+7.06%)

08/13/20 Piper Sandler
Akouos gearing up for 'busy' couple of years, says Piper Sandler
07/21/20 BTIG
Akouos initiated with a Buy at BTIG
07/21/20 BofA
Akouos initiated with a Buy at BofA
07/21/20 Cowen
Akouos initiated with an Outperform at Cowen
AKUS Akouos
$19.86 /

+1.31 (+7.06%)

  • 26
    Jun
Conference/Events
Standard Chartered management to meet virtually with JPMorgan » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
SCBFF

Standard Chartered

$0.00 /

+ (+0.00%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
SCBFF Standard Chartered
$0.00 /

+ (+0.00%)

02/24/21 Investec
Standard Chartered downgraded to Hold from Buy at Investec
02/08/21 Investec
Standard Chartered upgraded to Buy from Hold at Investec
01/20/21 Citi
Standard Chartered downgraded to Neutral from Buy at Citi
01/11/21 Deutsche Bank
Standard Chartered price target raised to 560 GBp from 480 GBp at Deutsche Bank
SCBFF Standard Chartered
$0.00 /

+ (+0.00%)

Conference/Events
Mattel participates in a conference call hosted by Keybanc » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
MAT

Mattel

$19.64 /

-0.08 (-0.41%)

KeyBanc to host…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
MAT Mattel
$19.64 /

-0.08 (-0.41%)

MAT Mattel
$19.64 /

-0.08 (-0.41%)

02/25/21
Fly Intel: Top five analyst upgrades
02/25/21 Monness Crespi
Mattel upgraded to Buy on favorable risk/reward at Monness Crespi
02/25/21 Monness Crespi
Mattel upgraded to Buy from Neutral at Monness Crespi
02/25/21 JPMorgan
Mattel price target raised to $27 from $22 at JPMorgan
MAT Mattel
$19.64 /

-0.08 (-0.41%)

MAT Mattel
$19.64 /

-0.08 (-0.41%)

MAT Mattel
$19.64 /

-0.08 (-0.41%)

Conference/Events
Amedisys management to meet virtually with Truist » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
AMED

Amedisys

$263.46 /

-17.9 (-6.36%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
AMED Amedisys
$263.46 /

-17.9 (-6.36%)

AMED Amedisys
$263.46 /

-17.9 (-6.36%)

02/23/21 Benchmark
Amedisys price target raised to $325 from $275 at Benchmark
02/08/21 Deutsche Bank
Amedisys price target raised to $340 from $275 at Deutsche Bank
01/05/21 Truist
Amedisys price target raised to $325 from $280 at Truist
11/03/20 Barclays
Amedisys price target raised to $298 from $290 at Barclays
AMED Amedisys
$263.46 /

-17.9 (-6.36%)

AMED Amedisys
$263.46 /

-17.9 (-6.36%)

Conference/Events
Morgan Stanley autos/transport analysts to hold analyst/industry conference call » 04:55
02/26/21
02/26
04:55
02/26/21
04:55

Autos Analyst Jonas,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Wedbush payments/IT services analyst holds an analyst/industry conference call » 04:55
02/26/21
02/26
04:55
02/26/21
04:55

Payments/IT Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

Conference/Events
Benchmark aerospace analyst to hold analyst/industry conference call » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
HII

Huntington Ingalls

$183.10 /

-2.7 (-1.45%)

, GD

General Dynamics

$166.27 /

-1.94 (-1.15%)

, BWXT

BWX Technologies

$59.41 /

-0.9 (-1.49%)

, LMT

Lockheed Martin

$341.86 /

-4.88 (-1.41%)

, BA

Boeing

$216.40 /

-13.15 (-5.73%)

Aerospace/Defense &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HII Huntington Ingalls
$183.10 /

-2.7 (-1.45%)

GD General Dynamics
$166.27 /

-1.94 (-1.15%)

BWXT BWX Technologies
$59.41 /

-0.9 (-1.49%)

LMT Lockheed Martin
$341.86 /

-4.88 (-1.41%)

BA Boeing
$216.40 /

-13.15 (-5.73%)

HII Huntington Ingalls
$183.10 /

-2.7 (-1.45%)

01/06/21 Vertical Research
Huntington Ingalls downgraded to Hold from Buy at Vertical Research
12/04/20 Alembic Global
Huntington Ingalls upgraded to Overweight from Neutral at Alembic Global
10/02/20 JPMorgan
Huntington Ingalls price target lowered to $175 from $205 at JPMorgan
10/01/20 Barclays
Huntington Ingalls price target lowered to $160 from $190 at Barclays
GD General Dynamics
$166.27 /

-1.94 (-1.15%)

01/29/21 Susquehanna
General Dynamics price target raised to $180 from $162 at Susquehanna
11/03/20 Morgan Stanley
Morgan Stanley sees attractive buying opportunity in Defense stocks
10/29/20 Credit Suisse
General Dynamics price target lowered to $140 from $156 at Credit Suisse
10/02/20
Fly Intel: Top five analyst downgrades
BWXT BWX Technologies
$59.41 /

-0.9 (-1.49%)

01/07/21 Baird
BWX Technologies downgraded to Neutral from Outperform at Baird
10/15/20 BofA
BWX Technologies upgraded to Buy from Neutral at BofA
10/15/20 BofA
BWX Technologies upgraded to Buy from Neutral at BofA
06/22/20 Maxim
BWX Technologies price target raised to $72 from $62 at Maxim
LMT Lockheed Martin
$341.86 /

-4.88 (-1.41%)

01/27/21 Credit Suisse
Lockheed Martin price target lowered to $334 from $351 at Credit Suisse
01/07/21 Baird
Lockheed Martin downgraded to Neutral from Outperform at Baird
01/07/21 Jefferies
Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely
12/22/20 Credit Suisse
Lockheed Martin price target raised to $409 from $400 at Credit Suisse
BA Boeing
$216.40 /

-13.15 (-5.73%)

02/19/21 Benchmark
Boeing price target lowered to $270 from $290 at Benchmark
02/10/21 Deutsche Bank
Airbus initiated with a Buy at Deutsche Bank
01/29/21
Fly Intel: Top five analyst upgrades Spire
01/29/21 Morgan Stanley
Morgan Stanley double upgrades Boeing to Overweight after 'kitchen sink' Q4
HII Huntington Ingalls
$183.10 /

-2.7 (-1.45%)

GD General Dynamics
$166.27 /

-1.94 (-1.15%)

BWXT BWX Technologies
$59.41 /

-0.9 (-1.49%)

LMT Lockheed Martin
$341.86 /

-4.88 (-1.41%)

BA Boeing
$216.40 /

-13.15 (-5.73%)

GD General Dynamics
$166.27 /

-1.94 (-1.15%)

LMT Lockheed Martin
$341.86 /

-4.88 (-1.41%)

BA Boeing
$216.40 /

-13.15 (-5.73%)

GD General Dynamics
$166.27 /

-1.94 (-1.15%)

LMT Lockheed Martin
$341.86 /

-4.88 (-1.41%)

BA Boeing
$216.40 /

-13.15 (-5.73%)

HII Huntington Ingalls
$183.10 /

-2.7 (-1.45%)

LMT Lockheed Martin
$341.86 /

-4.88 (-1.41%)

BA Boeing
$216.40 /

-13.15 (-5.73%)

Conference/Events
Humanigen participates in a conference call with Cantor Fitzgerald » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
HGEN

Humanigen

$18.00 /

-1.26 (-6.54%)

Biopharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HGEN Humanigen
$18.00 /

-1.26 (-6.54%)

HGEN Humanigen
$18.00 /

-1.26 (-6.54%)

02/23/21 JPMorgan
Humanigen initiated with a Neutral at JPMorgan
01/20/21 Jefferies
Jefferies reads Humanigen COVID-19 trial change as 'sign of confidence'
12/23/20 National Securities
Humanigen initiated with a Buy at National Securities
12/22/20
Fly Intel: Top five analyst initiations
HGEN Humanigen
$18.00 /

-1.26 (-6.54%)

  • 18
    Sep
HGEN Humanigen
$18.00 /

-1.26 (-6.54%)

HGEN Humanigen
$18.00 /

-1.26 (-6.54%)

Conference/Events
A-Mark Precious Metals participates in a conference call with DA Davidson. » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
AMRK

A-Mark Precious Metals

$27.40 /

-0.21 (-0.76%)

Institutional investor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
AMRK A-Mark Precious Metals
$27.40 /

-0.21 (-0.76%)

AMRK A-Mark Precious Metals
$27.40 /

-0.21 (-0.76%)

02/10/21 Roth Capital
A-Mark Precious Metals price target raised to $60 from $45 at Roth Capital
09/28/20 Roth Capital
A-Mark Precious Metals price target raised to $45 from $33 at Roth Capital
08/24/20
Fly Intel: Top five analyst initiations
08/24/20 Roth Capital
A-Mark Precious Metals initiated with a Buy at Roth Capital
AMRK A-Mark Precious Metals
$27.40 /

-0.21 (-0.76%)

  • 04
    Mar
AMRK A-Mark Precious Metals
$27.40 /

-0.21 (-0.76%)

Conference/Events
UBS technology analyst to hold an analyst/industry conference call » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
ZS

Zscaler

$195.76 /

-12.01 (-5.78%)

Technology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

02/25/21 Credit Suisse
Ping Identity downgraded to Neutral from Outperform at Credit Suisse
02/22/21 RBC Capital
Zscaler price target raised to $240 from $205 at RBC Capital
02/16/21 Canaccord
Zscaler initiated with a Buy at Canaccord
01/20/21
Fly Intel: Top five analyst initiations
ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

ZS Zscaler
$195.76 /

-12.01 (-5.78%)

Conference/Events
Mattel participates in a conference call hosted by MKM Partners » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
MAT

Mattel

$19.64 /

-0.08 (-0.41%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
MAT Mattel
$19.64 /

-0.08 (-0.41%)

MAT Mattel
$19.64 /

-0.08 (-0.41%)

02/25/21
Fly Intel: Top five analyst upgrades
02/25/21 Monness Crespi
Mattel upgraded to Buy on favorable risk/reward at Monness Crespi
02/25/21 Monness Crespi
Mattel upgraded to Buy from Neutral at Monness Crespi
02/25/21 JPMorgan
Mattel price target raised to $27 from $22 at JPMorgan
MAT Mattel
$19.64 /

-0.08 (-0.41%)

MAT Mattel
$19.64 /

-0.08 (-0.41%)

MAT Mattel
$19.64 /

-0.08 (-0.41%)

Conference/Events
Humana management to meet virtually with Stephens » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
HUM

Humana

$380.69 /

-0.76 (-0.20%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUM Humana
$380.69 /

-0.76 (-0.20%)

HUM Humana
$380.69 /

-0.76 (-0.20%)

01/13/21 Deutsche Bank
DaVita price target raised to $150 from $105 at Deutsche Bank
01/06/21 Argus
Humana price target raised to $450 from $430 at Argus
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Humana upgraded to Outperform at RBC Capital on above-average MA growth
HUM Humana
$380.69 /

-0.76 (-0.20%)

HUM Humana
$380.69 /

-0.76 (-0.20%)

HUM Humana
$380.69 /

-0.76 (-0.20%)

Conference/Events
Hillenbrand management to meet virtually with DA Davidson » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
HI

Hillenbrand

$46.54 /

-1.065 (-2.24%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HI Hillenbrand
$46.54 /

-1.065 (-2.24%)

HI Hillenbrand
$46.54 /

-1.065 (-2.24%)

02/08/21 DA Davidson
Hillenbrand price target raised to $52 from $46 at DA Davidson
02/04/21 Barrington
Hillenbrand price target raised to $54 from $50 at Barrington
01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
11/16/20 DA Davidson
Hillenbrand price target raised to $44 from $42 at DA Davidson
HI Hillenbrand
$46.54 /

-1.065 (-2.24%)

HI Hillenbrand
$46.54 /

-1.065 (-2.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.